Titre : 1,2-Dihydroxy-benzène-3,5-disulfonate de disodium

1,2-Dihydroxy-benzène-3,5-disulfonate de disodium : Questions médicales fréquentes

Termes MeSH sélectionnés :

Sleep Initiation and Maintenance Disorders
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "1,2-Dihydroxy-benzène-3,5-disulfonate de disodium : Questions médicales les plus fréquentes", "headline": "1,2-Dihydroxy-benzène-3,5-disulfonate de disodium : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les 1,2-Dihydroxy-benzène-3,5-disulfonate de disodium : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-12", "dateModified": "2025-03-07", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "1,2-Dihydroxy-benzène-3,5-disulfonate de disodium" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Benzènesulfonates", "url": "https://questionsmedicales.fr/mesh/D001557", "about": { "@type": "MedicalCondition", "name": "Benzènesulfonates", "code": { "@type": "MedicalCode", "code": "D001557", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.645.600.080.050.100" } } }, "about": { "@type": "MedicalCondition", "name": "1,2-Dihydroxy-benzène-3,5-disulfonate de disodium", "alternateName": "1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt", "code": { "@type": "MedicalCode", "code": "D014013", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Alexis Pinet", "url": "https://questionsmedicales.fr/author/Alexis%20Pinet", "affiliation": { "@type": "Organization", "name": "BioCIS , Université Paris-Sud, CNRS, Université Paris-Saclay , Chatenay-Malabry 92290 , France." } }, { "@type": "Person", "name": "Bruno Figadère", "url": "https://questionsmedicales.fr/author/Bruno%20Figad%C3%A8re", "affiliation": { "@type": "Organization", "name": "BioCIS , Université Paris-Sud, CNRS, Université Paris-Saclay , Chatenay-Malabry 92290 , France." } }, { "@type": "Person", "name": "Laurent Ferrié", "url": "https://questionsmedicales.fr/author/Laurent%20Ferri%C3%A9", "affiliation": { "@type": "Organization", "name": "BioCIS , Université Paris-Sud, CNRS, Université Paris-Saclay , Chatenay-Malabry 92290 , France." } }, { "@type": "Person", "name": "Kazuto Ikemoto", "url": "https://questionsmedicales.fr/author/Kazuto%20Ikemoto", "affiliation": { "@type": "Organization", "name": "Niigata Research Laboratory, Mitsubishi Gas Chemical Co, Inc., Niigata, Japan." } }, { "@type": "Person", "name": "Hidehiro Uekusa", "url": "https://questionsmedicales.fr/author/Hidehiro%20Uekusa", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, School of Science, Tokyo Institute of Technology, Tokyo 152-8551, Japan." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Knowledge, attitude, and practice toward sleep disorders and sleep hygiene among perimenopausal women.", "datePublished": "2024-05-22", "url": "https://questionsmedicales.fr/article/38777871", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-024-62502-4" } }, { "@type": "ScholarlyArticle", "name": "Sleep Disturbances in Children with Attentional Deficit Hyperactivity Disorder and Specific Learning Disorders.", "datePublished": "2022-05-25", "url": "https://questionsmedicales.fr/article/35681996", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph19116411" } }, { "@type": "ScholarlyArticle", "name": "Impact of sleep disorders and disease duration on neurotrophins levels in cocaine use disorder.", "datePublished": "2022-07-16", "url": "https://questionsmedicales.fr/article/35850320", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.neulet.2022.136805" } }, { "@type": "ScholarlyArticle", "name": "Sex differences in the effects of sleep disorders on cognitive dysfunction.", "datePublished": "2023-01-27", "url": "https://questionsmedicales.fr/article/36716906", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.neubiorev.2023.105067" } }, { "@type": "ScholarlyArticle", "name": "Occupational Exposure to Pesticides as a Risk Factor for Sleep Disorders.", "datePublished": "2023-02-10", "url": "https://questionsmedicales.fr/article/36833840", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph20043149" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés chimiques organiques", "item": "https://questionsmedicales.fr/mesh/D009930" }, { "@type": "ListItem", "position": 3, "name": "Composés du soufre", "item": "https://questionsmedicales.fr/mesh/D013457" }, { "@type": "ListItem", "position": 4, "name": "Acides du soufre", "item": "https://questionsmedicales.fr/mesh/D013456" }, { "@type": "ListItem", "position": 5, "name": "Acides sulfoniques", "item": "https://questionsmedicales.fr/mesh/D013451" }, { "@type": "ListItem", "position": 6, "name": "Acides arènesulfoniques", "item": "https://questionsmedicales.fr/mesh/D017739" }, { "@type": "ListItem", "position": 7, "name": "Arènesulfonates", "item": "https://questionsmedicales.fr/mesh/D001190" }, { "@type": "ListItem", "position": 8, "name": "Benzènesulfonates", "item": "https://questionsmedicales.fr/mesh/D001557" }, { "@type": "ListItem", "position": 9, "name": "1,2-Dihydroxy-benzène-3,5-disulfonate de disodium", "item": "https://questionsmedicales.fr/mesh/D014013" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : 1,2-Dihydroxy-benzène-3,5-disulfonate de disodium - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur 1,2-Dihydroxy-benzène-3,5-disulfonate de disodium", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur 1,2-Dihydroxy-benzène-3,5-disulfonate de disodium", "description": "Comment le 1,2-Dihydroxy-benzène-3,5-disulfonate est-il utilisé en diagnostic ?\nQuels tests nécessitent ce composé ?\nY a-t-il des tests spécifiques pour évaluer son efficacité ?\nComment évaluer les réactions allergiques au produit ?\nQuelles sont les contre-indications au diagnostic avec ce produit ?", "url": "https://questionsmedicales.fr/mesh/D014013?mesh_terms=Sleep+Initiation+and+Maintenance+Disorders&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur 1,2-Dihydroxy-benzène-3,5-disulfonate de disodium", "description": "Quels symptômes peuvent survenir après l'administration ?\nComment reconnaître une réaction allergique ?\nLes effets secondaires sont-ils fréquents ?\nQuels signes d'intolérance au produit ?\nY a-t-il des symptômes graves à surveiller ?", "url": "https://questionsmedicales.fr/mesh/D014013?mesh_terms=Sleep+Initiation+and+Maintenance+Disorders&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur 1,2-Dihydroxy-benzène-3,5-disulfonate de disodium", "description": "Comment prévenir les réactions allergiques ?\nDes tests préalables sont-ils recommandés ?\nQuelles précautions avant l'administration ?\nY a-t-il des recommandations alimentaires ?\nComment informer le personnel médical ?", "url": "https://questionsmedicales.fr/mesh/D014013?mesh_terms=Sleep+Initiation+and+Maintenance+Disorders&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur 1,2-Dihydroxy-benzène-3,5-disulfonate de disodium", "description": "Quel traitement en cas de réaction allergique ?\nComment gérer les effets secondaires ?\nY a-t-il un antidote pour ce composé ?\nQuand consulter un médecin après administration ?\nDes traitements préventifs existent-ils ?", "url": "https://questionsmedicales.fr/mesh/D014013?mesh_terms=Sleep+Initiation+and+Maintenance+Disorders&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur 1,2-Dihydroxy-benzène-3,5-disulfonate de disodium", "description": "Quelles complications peuvent survenir ?\nComment gérer une complication grave ?\nY a-t-il des risques à long terme ?\nQuels sont les signes de complications ?\nDes complications spécifiques aux reins ?", "url": "https://questionsmedicales.fr/mesh/D014013?mesh_terms=Sleep+Initiation+and+Maintenance+Disorders&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur 1,2-Dihydroxy-benzène-3,5-disulfonate de disodium", "description": "Quels sont les facteurs de risque d'allergie ?\nLes personnes âgées sont-elles plus à risque ?\nY a-t-il des risques liés à d'autres médicaments ?\nLes antécédents familiaux influencent-ils le risque ?\nLes maladies préexistantes augmentent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D014013?mesh_terms=Sleep+Initiation+and+Maintenance+Disorders&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment le 1,2-Dihydroxy-benzène-3,5-disulfonate est-il utilisé en diagnostic ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Il est utilisé comme agent de contraste pour améliorer l'imagerie médicale." } }, { "@type": "Question", "name": "Quels tests nécessitent ce composé ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Il est souvent utilisé dans les tests d'imagerie par résonance magnétique (IRM)." } }, { "@type": "Question", "name": "Y a-t-il des tests spécifiques pour évaluer son efficacité ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des études cliniques évaluent son efficacité en tant qu'agent de contraste." } }, { "@type": "Question", "name": "Comment évaluer les réactions allergiques au produit ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des tests cutanés peuvent être réalisés pour détecter des allergies potentielles." } }, { "@type": "Question", "name": "Quelles sont les contre-indications au diagnostic avec ce produit ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents d'allergies aux agents de contraste sont des contre-indications." } }, { "@type": "Question", "name": "Quels symptômes peuvent survenir après l'administration ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des réactions allergiques, des nausées ou des maux de tête peuvent survenir." } }, { "@type": "Question", "name": "Comment reconnaître une réaction allergique ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Des démangeaisons, des éruptions cutanées ou un gonflement peuvent indiquer une allergie." } }, { "@type": "Question", "name": "Les effets secondaires sont-ils fréquents ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires sont rares mais peuvent survenir chez certains patients." } }, { "@type": "Question", "name": "Quels signes d'intolérance au produit ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs abdominales ou des vertiges peuvent indiquer une intolérance." } }, { "@type": "Question", "name": "Y a-t-il des symptômes graves à surveiller ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des difficultés respiratoires nécessitent une attention médicale immédiate." } }, { "@type": "Question", "name": "Comment prévenir les réactions allergiques ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Un historique médical complet aide à identifier les risques d'allergies." } }, { "@type": "Question", "name": "Des tests préalables sont-ils recommandés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des tests cutanés peuvent être effectués pour évaluer le risque d'allergie." } }, { "@type": "Question", "name": "Quelles précautions avant l'administration ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Informer le médecin des allergies antérieures et des médicaments en cours." } }, { "@type": "Question", "name": "Y a-t-il des recommandations alimentaires ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Aucune recommandation alimentaire spécifique n'est nécessaire avant l'examen." } }, { "@type": "Question", "name": "Comment informer le personnel médical ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Communiquer clairement tout antécédent d'allergie ou de réaction indésirable." } }, { "@type": "Question", "name": "Quel traitement en cas de réaction allergique ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "L'administration d'antihistaminiques ou de corticostéroïdes peut être nécessaire." } }, { "@type": "Question", "name": "Comment gérer les effets secondaires ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires légers peuvent être gérés avec des analgésiques et du repos." } }, { "@type": "Question", "name": "Y a-t-il un antidote pour ce composé ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas d'antidote spécifique, le traitement est symptomatique." } }, { "@type": "Question", "name": "Quand consulter un médecin après administration ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Consulter si des symptômes graves ou persistants apparaissent après l'administration." } }, { "@type": "Question", "name": "Des traitements préventifs existent-ils ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des antihistaminiques peuvent être administrés avant l'examen pour prévenir les allergies." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme des réactions anaphylactiques peuvent survenir, bien que rares." } }, { "@type": "Question", "name": "Comment gérer une complication grave ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Une intervention médicale immédiate est nécessaire en cas de complication grave." } }, { "@type": "Question", "name": "Y a-t-il des risques à long terme ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les risques à long terme sont généralement faibles, mais des études sont en cours." } }, { "@type": "Question", "name": "Quels sont les signes de complications ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs thoraciques, des difficultés respiratoires ou des éruptions cutanées." } }, { "@type": "Question", "name": "Des complications spécifiques aux reins ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des complications rénales peuvent survenir, surtout chez les patients à risque." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque d'allergie ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents d'allergies et les maladies respiratoires augmentent le risque." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées peuvent avoir un risque accru de réactions indésirables." } }, { "@type": "Question", "name": "Y a-t-il des risques liés à d'autres médicaments ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines interactions médicamenteuses peuvent augmenter le risque d'allergies." } }, { "@type": "Question", "name": "Les antécédents familiaux influencent-ils le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un historique familial d'allergies peut augmenter le risque individuel." } }, { "@type": "Question", "name": "Les maladies préexistantes augmentent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Certaines maladies comme l'asthme peuvent augmenter le risque de réactions." } } ] } ] }

Sources (10000 au total)

Impact of sleep disorders and disease duration on neurotrophins levels in cocaine use disorder.

Brain-derived neurotrophic factor (BDNF) and its precursor proBDNF contribute to brain plasticity and neuronal remodeling. Recently, the ratio between proBDNF and BDNF (RpB) has been proposed as a pos... Subjects with a moderate to severe CUD were recruited. ProBDNF, BDNF and consequently RpB values were analyzed using ELISA technique. Insomnia severity index (ISI) scale was used to assess the severit... Twenty-four subjects (mean age 39.3 ± 6.7 years) were recruited. Correlation analysis showed that lower values of RpB were associated with higher ISI score (r = -0.469; p = 0.021), longer history of c... These preliminary findings may offer a novel insight on neurobiological alterations sustaining cocaine use. Lower RpB, as observed both in high insomnia levels and in chronic cocaine use, could induce...

Relating parental stress with sleep disorders in parents and children.

To assess whether child sleep disorders positively correlate with parental insomnia, hypersomnia, and sleep apnea, and whether parental and child sleep disorders simultaneously positively associate wi... Analyses are based on 14,009 employees aged 18-64 with dependent children (n = 44,157) insured by Deseret Mutual Benefit Administrator (DMBA) in 2020. Rate ratios are adjusted for age, sex, and marita... The rate of parental stress is 3.00 (95% CI 2.33-4.85) times greater for those with insomnia and 1.88 (95% CI 1.59-2.22) times greater for those with sleep apnea. There is no increased risk of stress ... Better understanding the connection between parent and child sleep problems and parent stress, and modifying influences, may improve treatment of these disorders....

Sleep Symptoms and Disorders in Episodic Migraine: Assessment and Management.

We review research on sleep symptoms and disorders in patients with episodic migraine and propose a framework for evaluating sleep symptoms in this patient population.... Patients with episodic migraine consistently report poorer sleep on validated self-reports compared to those without migraine. In polysomnographic studies, children with migraine have objectively shor...

Distinct phenotypic clusters of sleep-disordered breathing and their association with medical care-seeking behaviour and sleep habits: the Guangdong Sleep Health Study.

Sleep-disordered breathing (SDB) is highly prevalent, but its rates of diagnosis and treatment are low. As a heterogeneous condition, it is associated with delayed diagnosis and/or suboptimal treatmen...